Citations 2
Mirikizumab Demonstrates Long-Term Efficacy on Histological Resolution in the Phase 3, Multicenter, Open-Label VIVID-2 Extension Study
Reinisch, W, Jairath, V, Protic, M, Hertogh, G De, Harpaz, N, Hisamatsu, T, D'Haens, G, Pai, R, Morris, N, Hozak, R, Yu, G, Durand, F, Magro, F, Reinisch, W, Protić, Marijana , Hertogh, G De, Harpaz, Noam , Hisamatsu, Tadakazu, D’Haens, Geert , Pai, Rish, Morris, Nathan , Hozak, Rebecca R., Durand, Frédérick
Zeitschrift für Gastroenterologie | June 8, 2026 | Volume: 64 | Issue: 05 | Pages: e139-e140
S982 Association of Histologic-Endoscopic Response and Long-Term Clinical Outcomes: Results From Phase 2 Mirikizumab Trial in Patients With Moderately-to-Severely Active Crohn’s Disease
Protić, Marijana , Reinisch, Walter , Pai, Rish K. , Lin, Zhantao, Hozak, Rebecca R., Carlier, Hilde, Margo, Fernando, Jairath, Vipul , Reinisch, Walter , Hertogh, Gert D. , Harpaz, Noam
American Journal of Gastroenterology | October 18, 2023 | Volume: 118 | Issue: 10S | Pages: S740-S741